Atlas Venture Advisors, Inc. Bicycle Therapeutics PLC Transaction History

Atlas Venture Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	SELL	$41.7 - $61.14 $12.8 Million - $18.8 Million	-307,696 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$27.0 - $32.28 $8.24 Million - $9.85 Million	-305,000 Reduced 49.78%	307,696 $9.34 Million
Q4 2020 Feb 01, 2021	SELL	$17.95 - $21.36 $12.5 Million - $14.8 Million	-694,269 Reduced 53.12%	612,696 $11 Million
Q3 2020 Nov 12, 2020	SELL	$15.3 - $20.8 $852,684 - $1.16 Million	-55,731 Reduced 4.09%	1,306,965 $24.9 Million
Q2 2019 Aug 06, 2019	BUY	$10.06 - $14.63 $13.7 Million - $19.9 Million	1,362,696 New	1,362,696 $13.7 Million

111

41M

3.4K

12.4K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $696M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Atlas Venture Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Atlas Venture Advisors, Inc. with notifications on news.